GENMAB Chart calendar Genmab
3fd2b19b0f3584321906df48ae.OYeoxqXGveRAgh_DPgNSe4eAgVxfGZ_hr-FAR-KpwA4.ANWejZyiyocfzkiKBlYZIbXxyS4Pe8mv35UxJpHlsU1a1uqMyK3IhwPUVg~ab646f21f4065527e12e2a245ee89264
Upcoming events on Genmab
Past events on Genmab
| 2024-06-15 10:30 am | European Hematology Association Meeting - Abstract Number :S234 |
| 2024-06-14 12:00 pm | European Hematology Association Meeting - Abstract Number :P1244 |
| 2024-06-14 12:00 pm | European Hematology Association Meeting - Abstract Number :P1133 |
| 2024-06-14 12:00 pm | European Hematology Association Meeting - Abstract Number :P1140 |
| 2024-06-14 12:00 pm | European Hematology Association Meeting - Abstract Number :P1121 |
| 2024-06-14 12:00 pm | European Hematology Association Meeting - Abstract Number :P1114 |
| 2024-06-14 12:00 pm | European Hematology Association Meeting - Abstract Number :P1161 |
| 2024-06-14 12:00 pm | European Hematology Association Meeting - Abstract Number :P1152 |
| 2024-06-14 12:00 pm | European Hematology Association Meeting - Abstract Number :P1151 |
| 2024-06-14 12:00 pm | European Hematology Association Meeting - Abstract Number :P1146 |
| 2024-06-14 08:45 am | European Hematology Association Meeting - Abstract Number :S239 |
| 2024-06-14 08:45 am | European Hematology Association Meeting - Abstract Number :S163 |
| 2024-06-14 03:00 am | European Hematology Association Meeting - Abstract Number :P2059 |
| 2024-06-14 03:00 am | European Hematology Association Meeting - Abstract Number :P2081 |
| 2024-06-14 03:00 am | European Hematology Association Meeting - Abstract Number :PB2955 |
| 2024-06-14 03:00 am | European Hematology Association Meeting - Abstract Number :P2060 |
| 2024-06-10 09:20 am | Goldman Sachs Global Healthcare Conference |
| 2024-06-03 10:00 am | American Society of Clinical Oncology Meeting - Abstract No:TPS7084 |
| 2024-06-03 10:00 am | American Society of Clinical Oncology Meeting - Abstract No:7039 |
| 2024-06-03 10:00 am | American Society of Clinical Oncology Meeting - Abstract No:7037 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million DKK | Released Forecast Spread | 5 366 5 159 4.02% | 10 111 9 843 2.72% | 8 482 8 376 1.26% | 14 595 14 068 3.75% | 16 474 16 380 0.58% | 19 809 |
|
EBITDA Million DKK | Released Forecast Spread | 2 777 2 460 12.89% | 6 572 6 099 7.75% | 3 266 3 111 4.98% | 6 719 6 371 5.46% | 5 616 5 721 -1.83% | 6 334 |
|
EBIT Million DKK | Released Forecast Spread | 2 638 2 317 13.83% | 6 313 5 967 5.79% | 3 018 2 960 1.96% | 6 357 6 008 5.81% | 5 321 5 398 -1.42% | 5 352 |
|
Earnings before Tax (EBT) Million DKK | Released Forecast Spread | 2 859 2 645 8.11% | 5 904 5 723 3.17% | 3 983 3 731 6.77% | 7 035 8 905 -21% | 5 637 6 236 -9.6% | 5 863 |
|
Net income Million DKK | Released Forecast Spread | 2 166 2 085 3.89% | 4 758 4 706 1.1% | 3 008 2 847 5.64% | 5 522 6 793 -18.71% | 4 352 4 989 -12.77% | 4 673 |
|
EPS DKK | Released Forecast Spread | 34,0 32,8 3.61% | 72,2 69,4 4.06% | 45,5 43,8 3.94% | 83,7 104 -19.22% | 66,0 76,2 -13.35% | 68,0 |
| Announcement Date | 19/02/20 | 23/02/21 | 16/02/22 | 22/02/23 | 14/02/24 | - |
Quarterly results
| Fiscal Period | December | 2020 S1 | 2021 S1 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million DKK | Released Forecast Spread | 6 343 6 164 2.9% | 3 553 3 224 10.2% | 2 619 2 538 3.19% | 2 119 2 074 2.15% | 3 162 2 833 11.6% | 5 281 5 136 2.82% | 4 087 3 634 12.46% | 5 227 4 727 10.57% | 2 854 2 809 1.62% | 4 198 4 070 3.13% | 7 052 6 896 2.26% | 4 744 4 474 6.03% | 4 678 4 610 1.48% | 4 143 3 978 4.15% | 4 991 | 9 039 | 5 284 | 5 549 | 5 229 |
|
EBITDA Million DKK | Released Forecast Spread | 4 583 4 480 2.3% | 1 345 980 37.24% | 1 016 776 30.87% | 529 358 47.73% | 1 263 1 312 -3.74% | 1 792 1 951 -8.15% | 1 953 1 583 23.36% | 2 974 2 708 9.84% | 458 583 -21.48% | 1 520 1 670 -8.96% | 1 978 2 145 -7.79% | 1 739 1 646 5.65% | 1 899 1 804 5.28% | 823 882 -6.66% | 1 511 | 2 412 | 1 711 | 2 081 | 2 850 |
|
EBIT Million DKK | Released Forecast Spread | 4 568 4 389 4.08% | 1 319 864 52.66% | 809 772 4.76% | 514 442 16.3% | 1 247 1 156 7.87% | 1 761 1 814 -2.92% | 1 931 1 541 25.34% | 2 665 2 314 15.17% | 437 527 -17.08% | 1 497 1 573 -4.85% | 1 934 1 977 -2.18% | 1 717 1 702 0.87% | 1 670 1 772 -5.73% | 801 788 1.64% | 391 | 2 229 | 1 631 | 1 831 | 1 547 |
|
Earnings before Tax (EBT) Million DKK | Released Forecast Spread | 4 682 4 682 0% | 1 846 1 759 4.95% | 966 772 25.06% | 612 499 22.59% | 2 489 1 183 110.39% | 3 101 1 932 60.51% | 3 272 1 584 106.63% | 662 2 199 -69.9% | 286 402 -28.85% | 1 723 1 602 7.57% | 2 009 1 927 4.26% | 2 702 1 774 52.33% | 926 1 888 -50.95% | 1 716 921 86.25% | 185 | 3 374 | 1 698 | 1 733 | 1 634 |
|
Net income Million DKK | Released Forecast Spread | 3 647 4 573 -20.25% | 1 402 1 372 2.19% | 716 603 18.69% | 465 357 30.19% | 1 891 913 107.1% | 2 356 1 469 60.38% | 2 582 1 187 117.46% | 584 1 556 -62.47% | 226 397 -43.08% | 1 357 1 204 12.72% | 1 583 1 503 5.32% | 2 129 1 382 54.01% | 640 1 439 -55.52% | 1 325 779 70.01% | 456 | 2 598 | 1 363 | 1 300 | 1 280 |
|
EPS DKK | Released Forecast Spread | 55,5 70,2 -20.91% | 21,3 20,9 1.67% | 10,8 9,25 16.99% | 7,05 5,39 30.88% | 28,7 13,8 106.99% | 35,7 22,1 61.58% | 39,2 18,3 113.88% | 8,82 23,2 -61.91% | 3,43 5,07 -32.28% | 20,6 19,3 7.03% | 24,0 22,7 5.86% | 32,3 21,2 52.42% | 9,67 23,0 -57.93% | 20,2 10,6 90.39% | -2,25 | 39,5 | 19,3 | 19,1 | 14,9 |
| Announcement Date | 12/08/20 | 11/08/21 | 16/02/22 | 11/05/22 | 10/08/22 | 10/08/22 | 09/11/22 | 22/02/23 | 10/05/23 | 03/08/23 | 03/08/23 | 07/11/23 | 14/02/24 | 02/05/24 | - | - | - | - | - |
More events
Past sector events for Genmab
| 2024-06-05 03:51 am | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
| 2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
